Veracyte, Inc. (VCYT) — Analyst outlook / Analyst consensus target is. Based on 20 analyst ratings, the consensus is bullish — 13 Buy, 6 Hold, 1 Sell.
The consensus price target is $44.50 (low: $37.00, high: $50.00), representing an upside of 29.7% from the current price $34.30.
Analysts estimate Earnings Per Share (EPS) of $0.36 and revenue of $0.44B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.31 vs est $0.36 (missed -13.9%). 2025: actual $0.84 vs est $1.66 (missed -49.5%). Analyst accuracy: 43%.
VCYT Stock — 12-Month Price Forecast
$44.50
▲ +29.74% Upside
Average Price Target
Based on 20 Wall Street analysts offering 12-month price targets for Veracyte, Inc., the average price target is $44.50, with a high forecast of $50.00, and a low forecast of $37.00.
The average price target represents a +29.74% change from the last price of $34.30.
Highest Price Target
$50.00
Average Price Target
$44.50
Lowest Price Target
$37.00
VCYT Analyst Ratings
Buy
Based on 20 analysts giving stock ratings to Veracyte, Inc. in the past 3 months
EPS Estimates — VCYT
43%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.31
vs Est $0.36
▼ 16.1% off
2025
Actual $0.84
vs Est $1.66
▼ 98.0% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — VCYT
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.446B
vs Est $0.444B
▲ 0.4% off
2025
Actual $0.517B
vs Est $0.512B
▲ 1.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
